FDA Inspection
MSD Ireland (Carlow)MSD Ireland (Carlow) – FDA Inspection, Apr 1, 2025
Record Details
This FDA Inspection record concerns MSD Ireland (Carlow), with an inspection on April 1, 2025, issued by the Office of Inspections and Investigations, covering biologics.
View Company Profile
ID · 8c886f7d-b033-4a3f-9a39-4ed8d0dc1cbf
Inspection Facts
- Inspection number
- 1266301
- FDA center
- Biologics
- Project area
- Vaccine, Allergenic, and Live Biotherapeutic Products
FDA Citations
3- 21 CFR 211.113(b)Procedures for sterile drug products
- 21 CFR 211.192Investigations of discrepancies, failures
- 21 CFR 211.42(c)(10)(iv)Environmental Monitoring System
Full citation text and observation details available on the Dashboard.
Other FDA inspections of MSD Ireland (Carlow)
6| Date | Classification | Office | Project area |
|---|---|---|---|
| May 28, 2024 | Not classified | Office of Inspections and Investigations | |
| April 21, 2023 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| June 7, 2022 | VAI | Center for Biologics Evaluation and Research | Vaccines and Allergenic Products |
| November 22, 2019 | VAI | Center for Biologics Evaluation and Research | Vaccines and Allergenic Products |
| August 22, 2017 | Not classified | Office of Inspections and Investigations |
Other documents for MSD Ireland (Carlow)
- FDA Inspection 1239350 - 2024-05-28
- FDA Inspection 1230982 - 2023-04-21
- FDA Inspection 1171315 - 2022-06-07
- FDA Inspection 1110715 - 2019-11-22
- FDA Inspection 1022960 - 2017-08-22
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.